Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
A whole genome sequence-based portrait of how the two basic mechanisms generating human diversity work Elucidates how women and men contribute differently to diversity; how the genome promotes and regulates diversity; and the link between the generation of diversity...
Scientists at deCODE genetics have found a variant that protects against nasal polyps and chronic rhinosinusitis. The study was published on the 14th of January in the online edition of Nature genetics. Nasal polyps are non-malignant, typically bilateral growths on...
Award by the American Society of Human Genetics
At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.